Immedica Pharma AB
Fred Bero currently serves as Vice President of Sales & Marketing at Immedica Pharma AB since February 2025. Prior to this role, Fred held the position of Senior Director, Head of Urea Cycle Disorder (UCD) Marketing & Sales for Ultra-Rare Medicines at Amgen from October 2023 to February 2025, and similarly led UCD Marketing & Sales at Horizon Therapeutics from January 2019 to October 2023. Fred's earlier experience includes roles such as Regional Sales Director and Director of Market Access Services at Horizon Therapeutics, and Senior District Sales Manager and Specialty District Sales Manager at Noven Pharmaceuticals. Fred began a career in sales management at Wyeth Pharmaceuticals, holding multiple positions including Area Development Manager. Fred earned a BA in Political Science and Communications from Dominican University and an MBA from Northern Illinois University.
This person is not in any teams
This person is not in any offices
Immedica Pharma AB
About Immedica Pharma Immedica is a fast-growing private niche pharma group. Its headquarter is based in Stockholm, Sweden, and it has commercial coverage across Europe and the Middle East. Welcome to the Immedica social media channels The Immedica social channels are set up to share news, updates, and company happenings with all visitors. And we want to get your input on our company information but due to the highly regulated industry we work in there are some topics that we cannot talk about online. And please note that postings by other visitors do not necessarily reflect the opinion of Immedica or confirm their accuracy. Immedica will routinely monitor comments and Immedica reserves the right to remove any posts that do not comply with our guidelines and to block anyone who violates them repeatedly. Examples of reasons for having a comment removed from a post on our social media might be: Your comment references a side effect or complaint If you would like to report an adverse event or side effects or reactions from an Immedica product it should be reported either directly to us on the Immedica Drug Safety page or to your physician. Your comment references a product or treatment As mentioned, before we work in a highly regulated industry that does not allow us to engage with the public in discussions about products – ours or other companies – or treatment options. We never provide healthcare advice; your doctor or health care provider is the person to ask. If you have a product enquiry, please email the Immedica medical department. Your comment contains abusive language We welcome your feedback, provided you share your view in a way that is respectful to our community. That it’s not inappropriate, off-topic, harassing, spamming in nature, or promoting/soliciting third-party sites, initiatives, or products Social media platforms may occasionally be unavailable, and we accept no responsibility for lack of service due to social media platform downtime.